| Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights | 08/13 18:54 | prnewswire.com |
| Inhibrx: Continued Advancement Even After INBRX-101 Sale To Sanofi | 06/07 14:42 | seekingalpha.com |
| Top 4 Health Care Stocks That Are Preparing To Pump This Month - Inhibrx Biosciences (NASDAQ:INBX) | 06/05 07:46 | benzinga.com |
| Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi | 05/24 16:00 | prnewswire.com |
| Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off | 05/10 18:36 | prnewswire.com |
| INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX | 05/09 15:36 | businesswire.com |
| Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger | 05/08 16:37 | prnewswire.com |
| Inhibrx, Inc. (INBX) Reports Q4 Loss, Tops Revenue Estimates | 02/28 11:25 | zacks.com |
| Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results | 02/28 09:15 | prnewswire.com |